MBOTライブシグナル | Getagraph.comで利益を最大化

買う 109571 min ago

@ $1.190

発行日: 13 2月 2024 @ 23:30

リターン: -16.02%

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:40):

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space...

Stats
本日の出来高	270 985
平均出来高	99 838.00
時価総額	14.39M
EPS	$0 ( 2024-03-29 )
次の収益日	( $-0.170 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.950
ATR14	$0.00500 (0.50%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Diaz-cartelle Juan	Buy	17 500	Stock Option (Right to Buy)
2024-02-22	Sharon Simon	Buy	17 500	Stock Option (Right to Buy)
2024-02-22	Vaknin Rachel	Buy	17 500	Stock Option (Right to Buy)
2024-02-22	Gadot Harel	Buy	80 000	Stock Option (Right to Buy)
2024-02-26	Gadot Harel	Buy	79 567	Stock Option (Right to Buy)

INSIDER POWER
94.50
Last 94 transactions
Buy: 3 051 480 \| Sell: 817 965

ボリューム相関

長: -0.09 (neutral)

短: 0.56 (weak)

Signal:(66.8) Neutral

Microbot Medical Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Microbot Medical Inc 相関 - 通貨/商品

-0.56
( weak negative )

0.60
( weak )

0.00
( neutral )

-0.44
( neutral )

-0.58
( weak negative )

0.59
( weak )

Microbot Medical Inc 財務諸表

Annual	2023
収益:	$0
総利益:	$-106 000 (0.00 %)
EPS:	$-1.050

FY	2023
収益:	$0
総利益:	$-106 000 (0.00 %)
EPS:	$-1.050

FY	2022
収益:	$0
総利益:	$-102 000 (0.00 %)
EPS:	$14.44

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.590

Financial Reports:

No articles found.

Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.